試驗|《細胞》子刊:煙酰胺核苷或有神經保護作用!首個一期臨床試驗顯示,口服其可改變帕金森病患者的腦代謝,減少炎性細胞因子,改善臨床癥狀( 三 )


[3] Bloem, B.R., Okun, M.S., and Klein, C. (2021). Parkinson’s disease. Lancet 397, 2284–2303.
[4] Lautrup, S., Sinclair, D.A., Mattson, M.P., and Fang, E.F. (2019). NAD+ in brain aging and neurodegenerative disorders. Cell Metab. 30, 630–655.
[5] Katsyuba, E., Romani, M., Hofer, D., and Auwerx, J. (2020). NAD+ homeostasis in health and disease. Nat. Metab. 2, 9–31.
[6] Johnson, S., and Imai, S.-I. (2018). NAD+ biosynthesis, aging, and disease. F1000Res. 7, 132.
【試驗|《細胞》子刊:煙酰胺核苷或有神經保護作用!首個一期臨床試驗顯示,口服其可改變帕金森病患者的腦代謝,減少炎性細胞因子,改善臨床癥狀】[8] Gonzalez-Hunt, C.P., and Sanders, L.H. (2021). DNA damage and repair in Parkinson’s disease: recent advances and new opportunities. J. Neurosci. Res. 99, 180–189.